Axillary lymph node metastasis in stage T1a breast cancer: A pathologic review of 82 patients

American Surgeon

Volumn 63, Issue 2, 1997, Pages 144-149

  Whitten, Thomas M ^a   Fraser, Helen R ^a   Christensen, Wayne N ^c   Turk, Peter S ^a,b  

^a PRESBYTERIAN HOSPITAL   (United States)

^b Randolph Surgical Associates   (United States)

^c NONE

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; AXILLARY LYMPH NODE; BREAST CANCER; CANCER DIAGNOSIS; CANCER STAGING; CANCER SURGERY; HISTOPATHOLOGY; HUMAN; LYMPH NODE DISSECTION; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY;

AXILLA; BREAST NEOPLASMS; CARCINOMA, DUCTAL, BREAST; FEMALE; HUMANS; INCIDENCE; LYMPH NODE EXCISION; LYMPH NODES; LYMPHATIC METASTASIS; MIDDLE AGED; NEOPLASM STAGING; REGISTRIES; RETROSPECTIVE STUDIES;

EID: 0031028431     PISSN: 00031348     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (38)

1. Fisher B, Bauer MJ, Wickerham DL, et al. Relation of number of positive nodes to the prognosis of patients with primary breast cancer. Cancer 1983;52:1551-7.
2. Fisher B, Slack NH. Number of lymph nodes examined and the prognosis of breast cancer. Surg Gynecol Obstet 1970;131:79- 88.
3. Kinne DW. Surgical management of stage I and II breast cancer. Cancer 1990;66 (Supplement):1333-7.
4. Silverstein MJ, Gierson ED, Waisman JR, et al. Axillary lymph node dissection for T1a breast carcinoma: Is it indicated? Cancer 1994;173:664-7.
5. Chadha M, Chabon AB, Friedmann P, Vikram B. Predictors of axillary lymph node metastases in patients with T1 breast cancer. Cancer 1994;73:350-3.
6. Bloom HJG, Richardson WW. Histological grading and prognosis in breast cancer. Br J Cancer 1957;11:359-77.
7. Beahrs OH, Henson DE, Hutler RVP, Kennedy BJ, eds. Manual for Staging of Cancer, Ed. 4. Philadelphia: JB Lippincott Co., 1992.
8. Carter CL, Allen C, Henson DE. Relation of tumor size, lymph node status, and survival in 24,740 breast cancer cases. Cancer 1989;63:181-7.
9. Cady B, Stone MD, Wayne J. New therapeutic possibilities in primary invasive breast cancer. Ann Surg 1993;218:338-49.
10. Deckers P. Axillary dissection in breast cancer: When, why, how much, and for how long? Another operation soon to be extinct? J Surg 1991;48:217-9.
11. Lin PP, Allison DC, Wainstock J, et al. Impact of axillary lymph node dissection on the therapy of breast cancer patients. J Clin Oncol 1993;11:1536-44.
12. Cady B. The need to reexamine axillary lymph node dissection in invasive breast cancer. Cancer 1994;173:505-6.
13. Haffty BG, McKhann C, Beinfield M, Fischer D, Fischer JJ. Breast conservation therapy without axillary dissection: A rational treatment strategy in selected patients. Arch Surg 1993;128:1315-9.
14. Wazer DE, Erban JK, Robert NJ, et al. Breast conservation in elderly women for clinically negative axillary lymph nodes without axillary dissection. Cancer 1994;74:878-83.
15. Kinne DW, Petrek JA, Osborne MP, et al. Breast carcinoma in situ. Arch Surg 1989;124:33-6.
16. Kopald KH, Hiatt JR, Irving C, Giuliano AE. The pathology of nonpalpable breast cancer. Am Surg 1990;56:782-7.
17. Simpson T, Thirby RC, Dail DH. Surgical treatment of ductal carcinoma in situ of the breast: 10- to 20-year follow-up. Arch Surg 1992;127:468-72.
18. Donegan WL. Prognostic factors: Stage and receptor status in breast cancer. Cancer 1992;70:1755-64.
19. Margolis DS, McMillen MA, Hashmi H, et al. Aggressive axillary evaluation and adjuvant therapy for nonpalpable carcinoma of the breast. Surg Gynecol Obstet 1992;174:109-13.
20. Winchester DJ, Menek HR, Fremgen AM, Winchester DP. Selection criteria for axillary dissection in breast cancer. Society of Surgical Oncology Annual Symposium Abstract 82, 1995.
21. Page DL, Anderson TJ, Connolly JL, Schnitt SJ. Miscella neous features of carcinoma. In: Page DL, Anderson TJ. Diagnostic histopathology of the breast. New York: Churchill Livingstone, 1987, pp269-99.
22. Reger V, Beito G, Jolly PC. Factors affecting the incidence of lymph node metastases in small cancers of the breast. Am J Surg 1989;501-2
23. Tinnemans JGM, Wobbes T, Holland R, et al. Treatment and survival of female patients with nonpalpable breast carcinoma. Ann Surg 1989;209:249-53.
24. Dowlatshahi K, Snider HC, Kim R. Axillary node status in nonpalpable breast cancer. Ann Surg Oncol 1995;2:424-8.
25. Wilhelm MC, Edge SB, Cole DD, deParedes E. Nonpalpable invasive breast cancer. Ann Surg 1991;213:600-5.
26. Seidman JD, Schnaper LA, Aisner SC. Relationship of the size of the invasive carcinoma to axillary lymph node metastasis. Cancer 1995;75:65-71.
27. McGuire WL, Tandon AK, Allred DC, Chamness GC, et al. Prognosis and treatment decisions in patients with breast cancer without axillary node involvement. Cancer 1992;70:1775-81.
28. Norris HJ, Taylor HB. Prognosis of mucinous (gelatinous) carcinoma of the breast. Cancer 1965;18:879-85.
29. Fisher ER, Palekar AS, Redmond C, et al. Pathologic findings from the National Surgical Adjuvant Breast Project (Protocol No. 4). VI. Invasive papillary carcinoma. Am J Clin Pathol 1980;73:313-22.
30. Peters GN, Wolff M, Haagensen CD. Tubular carcinoma of the breast. Ann Surg 1981;193:138-49.
31. Silverstein MJ, Gierson ED, Waisman JR, et al. Predicting axillary node positivity in patients with invasive carcinoma of the breast by using a combination of T category and palpability. J Am Coll Surg 1995;180:700-4.
32. Fisher B, Redmond C, Fisher ER, et al. Ten year results of a randomized clinical trial comparing radical mastectomy and total mastectomy with or without radiation. N Engl J Med 1985;312:674- 81.
33. Langlands AO, Prescott RJ, Hamilton T. A clinical trial in the management of operable cancer of the breast. Br J Surg 1980;67:170-4.
34. Benson EA, Thorogood J. The effect of surgical technique on local recurrence rates following mastectomy. Eur J Surg Oncol 1986;12:267-71.
35. Cabanes PA, Salmon RJ, Vilcoq JR, et al. Value of axillary dissection in addition to lumpectomy and radiotherapy in early breast cancer. Lancet 1992;339:1245-8.
36. Recht A. Controversies in the management of early-stage cancer of the breast with conservative surgery and radiotherapy. American Society for Therapeutic Radiology and Oncology (Annual Review) 1994.
37. Hoskin PJ, Rajan B, Ebbs S, et al. Selective avoidance of lymphatic radiotherapy in the conservative management of early breast cancer. Radiother Oncol 1992;25:83-8.
38. Halverson KJ, Taylor ME, Pereze CA, et al. Regional nodal management and the patterns of failure following conservative surgery and radiation therapy for stage I and II breast cancer. Radiat Oncol Biol Phys 1993;26:593-99.